Skip to main content
Log in

‘Natural Remedies’ in the Treatment of Osteoarthritis

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Osteoarthritis (OA) is a common, chronic and painful condition. It is the most common of all rheumatic disorders and is destined to become one of the most prevalent and costly diseases in our society. The conventional therapeutic options employed in the management of OA are simple analgesics and NSAIDs, but these options frequently produce sub-optimal benefit and are associated with an adverse-safety profile. Unsurprisingly patients are looking to alternative and complementary medicine.

The aim of this article was to review the available literature on the effectiveness and safety of ‘natural remedies’ for the treatment of OA. Computerised literature searches were carried out for systematic reviews and randomised controlled trials examining the role of ‘natural remedies’ in the treatment of OA.

There have been few randomised controlled trials of ‘natural remedies’ that have satisfied the internationally agreed standards. There was, however, evidence of efficacy for glucosamine, chondroitin sulfate and possibly avocado/soybean unsaponifiables for the symptomatic relief of OA. To date, it is not established whether any of the ‘natural remedies’ are capable of chondroprotection.

Even if ‘natural remedies’ are only modestly effective, they are widely available and well tolerated, suggesting that they may play a significant role in the management of OA in the elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Notes

  1. Use of tradenames is for product identification only and does not imply endorsement.

References

  1. Lawrence R, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989; 16: 427–41

    PubMed  CAS  Google Scholar 

  2. Hochberg MC. Epidemiologic considerations in the primary prevention of osteoarthritis. J Rheumatol 1991; 18: 1438–40

    PubMed  CAS  Google Scholar 

  3. Murray CJL, Lopez A. The global burden of disease. Geneva: World Health Organization, 1997

    Google Scholar 

  4. Eccles M, Freemantle N, Mason J, for the North of England Non-Steroidal Anti-Inflammatory Drug Guidelines Development Group. North of England evidence based guidelines development project: summary guidelines for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. BMJ 1998; 317: 526–30

    Article  PubMed  CAS  Google Scholar 

  5. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–75

    Article  PubMed  CAS  Google Scholar 

  6. Rao JK, Mihaliak K, Kroenke K, et al. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131: 409–16

    PubMed  CAS  Google Scholar 

  7. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548–53

    Article  PubMed  CAS  Google Scholar 

  8. Bellamy N, Buchanan WW. Outcome measurement in osteoarthritis clinical trials: the case for standardization. Clin Rheumatol 1984; 3: 293–305

    Article  PubMed  CAS  Google Scholar 

  9. Lequesne M, Brandt K, Bellamy N, et al. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol Suppl 1994; 41: 65–71

    PubMed  CAS  Google Scholar 

  10. Bellamy N, Kirwan J, Boers M, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis: consensus development at OMERACT III. J Rheumatol 1996; 24(4): 799–802

    Google Scholar 

  11. Walker-Bone K, Javaid MK, Arden N, et al. Medical management of osteoarthritis. BMJ 2000; 321: 936–40

    Article  PubMed  CAS  Google Scholar 

  12. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936–44

    Article  PubMed  CAS  Google Scholar 

  13. Chard J, Dieppe P. The case for nonpharmacologic therapy of osteoarthritis. Curr Rheumatol Rep 2001; 3: 251–7

    PubMed  CAS  Google Scholar 

  14. Moore RA, Tramer MR, Carroll D, et al. Topical non-steroidal anti-inflammatory drugs are effective and safe for osteoarthritis. BMJ 1998; 316: 333–8

    Article  PubMed  CAS  Google Scholar 

  15. Fusco BM, Giacovazzo M. Peppers and pain — the promise of capsaicin. Drugs 1997; 53: 909–14

    Article  PubMed  CAS  Google Scholar 

  16. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991; 13: 383–95

    PubMed  CAS  Google Scholar 

  17. McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol 1992; 19: 604–7

    PubMed  CAS  Google Scholar 

  18. Schinitzer TJ, Morton C, Coker S, et al. The effectiveness of reduced applications of topical capsaicin (0.025%) in osteoarthritis [abstract]. Arthritis Rheum 1992; 35: S132

    Google Scholar 

  19. Altman RD, Aven A, Holmburg CE, et al. Capsaicin cream 0.025% as monotherapy for osteoarthritis: a double blind study. Semin Arthritis Rheum 1994; Suppl. 23: 25–33

    Google Scholar 

  20. McCleane G. The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study. Eur J Pain 2000; 4: 355–60

    Article  PubMed  CAS  Google Scholar 

  21. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. Eur J Clin Pharmacol 1994; 46: 517–22

    Article  PubMed  CAS  Google Scholar 

  22. Randall C, Randall H, Dobbs F, et al. Randomised controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med 2000; 93: 305–9

    PubMed  CAS  Google Scholar 

  23. Long L, Soeken K, Ernst E. Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology 2001; 40: 779–93

    Article  PubMed  CAS  Google Scholar 

  24. Kulkarni R, Patki P, Jog V, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991; 33: 91–5

    Article  PubMed  CAS  Google Scholar 

  25. Lanhers M, Fleurentin J, Mortier F, et al. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 1992; 58: 117–23

    Article  PubMed  CAS  Google Scholar 

  26. Baghdikian B, Lanhers M, Fleurentin J, et al. An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med 1997; 63(2): 171–6

    Article  PubMed  CAS  Google Scholar 

  27. Bhattacharya A, Bhattachraya S. Anti-oxidant activity of Harpagophytum procumbens (Devil’s Claw). Br J Phytotherapy 2002; 5: 68–71

    Google Scholar 

  28. Guyader M. Les plantes antirhumatismales. Etude historique et pharmacologique, et etude clinique du nebulisat d’Hargophytum procumbens DC chez 50 patients arthrosiques suivis en service hospitalier [PhD thesis]. Paris: Universite Pierre et Marie Curie, 1984

    Google Scholar 

  29. Lecomte A, Costa JP. Hapagophytum dans l’arthrose: Etudes en double insu contre placebo. Le Magazine 1992; 15: 27–30

    Google Scholar 

  30. Piscoya J, Rodriguez Z, Bustamunte S, et al. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee:mechanisms of action of the species Uncaria guianensis. Inflamm Res 2001; 50: 442–8

    Article  PubMed  CAS  Google Scholar 

  31. Bliddal H, Resetzsky A, Schlichting P, et al. A randomised, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthritis Cartilage 2000; 8: 9–12

    Article  PubMed  CAS  Google Scholar 

  32. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001; 44: 2461–2

    Article  Google Scholar 

  33. Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. CD002947. Oxford: Update Software, 2001

    Google Scholar 

  34. Ryttig K, Schlamowitz P, Warnoe O, et al. Gitadyl versus ibuprofen in patients with osteoarthrosis: the result of a double-blind, randomized cross-over study. Ugeskr Laeger 1991; 153: 2298–9

    PubMed  CAS  Google Scholar 

  35. Ernst E. The efficacy of phytodolor for the treatment of musculoskeletal pain: a systematic review of randomized clinical trials. Natural Medicine Online 2000; 3(2)

    Google Scholar 

  36. Hawel R. Phytodolor vs Diclofenac bei rheumatischen Erkrankungen. Interner Forschungsbericht. Darmstadt: Steigerwald GmbH, 1991

    Google Scholar 

  37. Huber V. Therapie degenerativer rheumatischer Erkrankungen. Fortschr Med 1991; 109: 248–50

    PubMed  CAS  Google Scholar 

  38. Schadler W. Phytolodor N zur Behandlung aktivierter Arthrosen. Rheumatologika 1988; 8: 280–90

    Google Scholar 

  39. Baumann D, Focke G, Kornosoff G. Phytodolor bei patienten mit aktivierter Gonarthrose, Koxarthrose bzw. Schulter-Arm-Syndrom. multizentrische randomisierte Doppelblindstudie versus Diclofenac-Natrium. Interner Forschungsbericht. Darmstadt: Steigerwald GmbH, 1989

    Google Scholar 

  40. Mills SY, Jacoby RK, Chacksfield M, et al. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: a double-blind study. Br J Rheumatol 1996; 35: 874–8

    Article  PubMed  CAS  Google Scholar 

  41. Schmid B, Ludtke R, Selbmann H, et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double-blind clinical trial. Phytother Res 2001; 15: 344–50

    Article  PubMed  CAS  Google Scholar 

  42. Ferraz M, Pereira R, Iwata N, et al. A popular analgesic tea: a double-blind cross-over trial in osteoarthritis. Clin Exp Rheumatol 1991; 9: 205–6

    PubMed  CAS  Google Scholar 

  43. Boumediene K, Felisaz N, Bogdanowicz P, et al. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in clutured articular chondrocytes. Arthritis Rheum 1999; 42: 148–56

    Article  PubMed  CAS  Google Scholar 

  44. Henrotin Y, Labasse A, Jaspar J, et al. Effects of three avocado/ soybean unsaponifiable mixtures on metalloproteinases, cytokines, and prostaglandin E2 production by human articular chondrocytes. Clin Rheumatol 1998; 17: 31–9

    Article  PubMed  CAS  Google Scholar 

  45. Appelboom T, Schuermans J, Verbruggen G, et al. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. Scand J Rheumatol 2001; 30: 242–7

    Article  PubMed  CAS  Google Scholar 

  46. Blotman F, Maheu E, Wulwik A, et al. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. Rev Rhum Mal Osteoartic 1997; 41: 825–34

    Google Scholar 

  47. Maheu E, Mazieres B, Valat J, et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, doubleblind, placebo-controlled, multicenter clinical trial with six months treatment and a two-month follow-up demonstrating a persistent effect. Arthritis Rheum 1998; 41: 81–91

    Article  PubMed  CAS  Google Scholar 

  48. Lequesne M, Maheu E, Cadet C, et al. Structural effect of avocado/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum 2002; 47: 50–8

    Article  PubMed  CAS  Google Scholar 

  49. Theodosakis J, Adderly B, Fox B. The arthritis cure. New York: St Martin’s Press, 1997

    Google Scholar 

  50. McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis. JAMA 2000; 283: 1469–75

    Article  PubMed  CAS  Google Scholar 

  51. Adams ME. Hype about glucosamine. Lancet 1999; 354: 353–4

    Article  PubMed  CAS  Google Scholar 

  52. Hughes R. Oral glucosamine sulphate in the treatment of osteoarthritis: a review of the literature. Ann Rheum Dis 1999; 8(EULAR Suppl.): 124

    Google Scholar 

  53. Delafuente JC. Glucosamine in the treatment of osteoarthritis. Rheum Dis Clin North Am 2000; 26: 1–11

    Article  PubMed  CAS  Google Scholar 

  54. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 1. CD002946. Oxford: Update Software, 2001

    Google Scholar 

  55. Chard J, Dieppe P. Glucosamine for osteoarthritis: magic, hype or confusion? BMJ 2001; 322: 1439

    Article  PubMed  CAS  Google Scholar 

  56. Hughes RA, Carr AJ. A randomised, double-blind, placebo-controlled trial of glucosamine to control pain in osteoarthritis of the knee [abstract]. Arthritis Rheum 2000; 45: S384

    Google Scholar 

  57. Reginster J, Deroisy R, Rovati LC, et al. Glucosamine sulfate significantly reduces progession of knee osteoarthritis over 3 years: a large, randomised, placebo-controlled prospective trial. Lancet 2001; 357: 251–6

    Article  PubMed  CAS  Google Scholar 

  58. Brief AA, Maurer SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis. J Am Acad Orthop Surg 2001; 9: 352–3

    Google Scholar 

  59. Hauselmann HJ. Nutripharmaceuticals for osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15: 595–607

    Article  PubMed  CAS  Google Scholar 

  60. Creamer P, Lethbridge-Cejku M, Hochberg MC. Factors associated with functional impairment in symptomatic knee osteoarthritis. Rheumatology 2000; 39: 490–6

    Article  PubMed  CAS  Google Scholar 

  61. Kelly GS. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alternative Med Rev 1998; 3: 27–39

    CAS  Google Scholar 

  62. Walker-Bone K, Javaid MK, Arden N, et al. Glucosamine and chondroitin may help in osteoarthritis [letter]. BMJ 2001; 322: 673

    Article  PubMed  CAS  Google Scholar 

  63. Leeb BF, Schweitzer H, Montag K, et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2001; 27: 205–11

    Google Scholar 

  64. Leeb BF. Management of knee osteoarthritis. Ann Rheum Dis 2001; 60: 984

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this manuscript. The author has no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen Walker-Bone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walker-Bone, K. ‘Natural Remedies’ in the Treatment of Osteoarthritis. Drugs Aging 20, 517–526 (2003). https://doi.org/10.2165/00002512-200320070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200320070-00004

Keywords

Navigation